July 12, 2016
Author: Kaspar van den Dries, Ph.D.
In this webinar, experts will explain the benefits of considering lipid formulation early in the development process and how a structured screening and development approach can assist in overcoming potential barriers associated with lipid formulations.
Martin Piest, PhD, Senior Formulation Scientist
Kaspar van den Dries, PhD, Senior Director and Principle Scientist, Solid Dose Development at Patheon